Global Rare Hemophilia Factors Market to Reach $471.2 Million by 2030
The global market for Rare Hemophilia Factors estimated at US$323.7 Million in the year 2023, is expected to reach US$471.2 Million by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Fresh Frozen Plasma Treatment, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$224 Million by the end of the analysis period. Growth in the Factor Concentrates Treatment segment is estimated at 6.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $98 Million, While China is Forecast to Grow at 5.3% CAGR
The Rare Hemophilia Factors market in the U.S. is estimated at US$98 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$83.1 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 4.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook